Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma

Auel, Britta; Goldschmidt, Hartmut; Geer, Thomas; Moehler, Thomas M.; Platzbecker, Uwe; Naumann, Ralph; Blau, Igor; Haenel, Mathias; Knauf, Wolfgang; Nueckel, Holger; Salwender, Hans-Juergen; Scheid, Christof; Weisel, Katja; Gorschlueter, Marcus; Glasmacher, Axel; Schmidt-Wolf, Ingo G. H.

Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma

Autor(en):

Auel, Britta; Goldschmidt, Hartmut; Geer, Thomas; Moehler, Thomas M.; Platzbecker, Uwe; Naumann, Ralph; Blau, Igor; Haenel, Mathias; Knauf, Wolfgang; Nueckel, Holger; Salwender, Hans-Juergen; Scheid, Christof; Weisel, Katja; Gorschlueter, Marcus; Glasmacher, Axel; Schmidt-Wolf, Ingo G. H.

Tübinger Autor(en):

Weisel, Katja

Erschienen in:

Indian Journal of Hematology and Blood Transfusion (2012), Bd. 28, H. 2, S. 67-76

Verlagsangabe:

Springer India

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1007/s12288-011-0103-1

ISSN:

0971-4502